Appointment Enhances Leadership Team with Deep Sterile Injectables Expertise and Ability to Drive the Company’s Global R&D Strategy and Execution ST. LOUIS, Jan. 12, 2026
The TruDelivery® RTU portfolio helps meet the real-world challenges of hospital pharmacies — and is always ready when you are. It’s about time. Company BackgroundEndo
Proud to showcase at the ASHP Midyear Clinical Meeting and Exhibition last week! Our Sterile Injectables team had great conversations with pharmacy professionals and industry
ASHP Midyear 2025 Clinical Meeting & Exhibition December 8-10, 2025 | Las Vegas, NV Featuring some of the most innovative technologies and products, the exhibit
Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables Poised for Long-Term
Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of a generic version of Amgen’s RAVICTI® (glycerol phenylbutyrate), 1.1 gm/mL oral liquid, following final approval from
Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN® (epinephrine in 0.9% sodium chloride injection) premixed IV bags in three new concentrations: 2 mg/250
Endo has introduced new 2 mg/250 mL, 5 mg/250 mL, and 10 mg/250 mL concentrations of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) premixed IV bag. This manufacturer-prepared
The TruDelivery® RTU portfolio helps meet the real-world challenges of hospital pharmacies — and is always ready when you are. It’s about time. Company BackgroundEndo
– Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs– Respective Generics Businesses and Endo’s Sterile Injectables Business to be Combined and Spun